Ratings by JMP Securities (Jason N. Butler)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/18/2021 Concert Pharmaceuticals CNCE Maintain Market Outperform
(Market Outperform)
 
 
  Details
4/5/2021 Acadia Pharmaceuticals ACAD Maintain Market Outperform
(N/A)
 
 
  Details
3/4/2021 Adamas Pharmaceuticals ADMS Maintain Market Outperform
(N/A)
 
 
  Details
3/1/2021 PLx Pharma PLXP Maintain Market Outperform
(N/A)
 
 
  Details
2/17/2021 Baudax Bio Inc. BXRX Maintain Market Outperform
(Market Outperform)
 
 
  Details
2/10/2021 Gamida Cell Ltd. GMDA Maintain Market Outperform
(Market Outperform)
 
 
  Details
2/1/2021 Concert Pharmaceuticals CNCE Maintain Market Outperform
(N/A)
 
 
  Details
12/28/2020 Myovant Sciences Ltd. MYOV Maintain Market Outperform
(N/A)
 
 
  Details
12/21/2020 Myovant Sciences Ltd. MYOV Maintain Market Perform
(N/A)
 
 
  Details
12/10/2020 Neos Therapeutics NEOS Downgrade Market Perform
(Market Outperform)
0.55
(1.15)
109.09% Details
12/2/2020 Ovid Therapeutics Inc OVID Downgrade Market Perform
(Market Outperform)
6.84
(4.26)
-37.72% Details
11/12/2020 MorphoSys AG MOR Maintain Market Outperform
(N/A)
 
 
  Details
10/20/2020 Baudax Bio Inc. BXRX Maintain Market Outperform
(N/A)
 
 
  Details
9/9/2020 Intra-Cellular Therapies ITCI Maintain Market Outperform
(N/A)
 
 
  Details
8/10/2020 Trevena TRVN Maintain Market Outperform
(N/A)
 
 
  Details
8/6/2020 Syros Pharmaceuticals SYRS Maintain Market Outperform
(N/A)
 
 
  Details
7/13/2020 Ovid Therapeutics Inc OVID Maintain Market Outperform
(N/A)
 
 
  Details
6/5/2020 Minerva Neurosciences NERV New Coverage Market Outperform
(N/A)
4.26
(2.46)
-42.25% Details
5/21/2020 Gamida Cell Ltd. GMDA Maintain Market Outperform
(N/A)
 
 
  Details
10/7/2019 Pfenex Inc. PFNX Maintain Market Outperform
(N/A)
 
 
  Details